Areti Pagiantza
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Radial artery occlusion after cardiac catheterization and impact of anticoagulation as medical treatment: a meta-analysis.
Journal: Coronary artery disease
Published: February 20, 2025
Treatment of radial artery occlusion after transradial coronary catheterization: a review of the literature and proposed treatment algorithm.
Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
Published: October 31, 2024
Incidence and Prognostic Factors of Radial Artery Occlusion in Transradial Coronary Catheterization.
Incidence and Prognostic Factors of Radial Artery Occlusion in Transradial Coronary Catheterization.
Journal: Journal of clinical medicine
Published: April 08, 2024
Low Molecular Weight Heparin in Improving RAO After Transradial Coronary Catheterization: The LOW-RAO Randomized Study.
Journal: JACC. Cardiovascular interventions
Published: May 27, 2022
Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis.
Journal: Open heart
Published: December 13, 2021
Low-molecular-weight heparin in radial artery occlusion treatment: the LOW-RAO randomized study.
Journal: Future cardiology
Published: August 16, 2021
Comparative efficacy and safety of oral P2Y12 inhibitors for patients with chronic kidney disease and acute coronary syndrome: a network meta-analysis.
Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
Published: March 12, 2021
Lipoprotein(a) Reduction With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-analysis.
Journal: Journal of cardiovascular pharmacology
Published: October 07, 2020
Cardio-protective Effects of Glucagon-like Peptide-1 Receptor Agonists: An Overview of Systematic Reviews and Publication Overlap.
Journal: Current pharmaceutical design
Published: September 30, 2020
Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome.
Journal: The American journal of cardiology
Published: April 22, 2020
Last Updated: 09/26/2026